BIOMAT Database Logo BIOMAT Database Logo

Immunochemical approaches to AGE-structures: characterization of anti-AGE antibodies. 1998

K Ikeda, and R Nagai, and T Sakamoto, and H Sano, and T Araki, and N Sakata, and H Nakayama, and M Yoshida, and S Ueda, and S Horiuchi
Department of Biochemistry, Kumamoto University, School of Medicine, Honjo, Japan.

Recent immunological approaches have greatly helped broaden our understanding of the biomedical significance of advanced glycation end products (AGEs) in aging and age-enhanced disease processes. Recently, Nepsilon-(carboxymethyl) lysine (CML), one of the glycoxidation products of AGEs, was demonstrated to be a major immunological epitope among AGEs. In the subsequent study, we characterized 13 different polyclonal anti-AGE antibodies and showed that these antibodies could be classified into three groups (Groups I, II and III). Group I was specific for CML and both Group II and Group III were specific for other epitopes (non-CML). Time-course study suggested that the epitope of Group II was formed earlier than that of Group III. In the present study, we prepared two monoclonal anti-AGE antibodies (2A2 and 3A3) whose epitope structures appeared to be closely related to Group III and Group II, respectively. The result indicates that AGE-proteins express at least two major non-CML epitopes.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

K Ikeda, and R Nagai, and T Sakamoto, and H Sano, and T Araki, and N Sakata, and H Nakayama, and M Yoshida, and S Ueda, and S Horiuchi
[Immunochemical characterization of anti-erythrocyte antibodies].
January 1967, Folia allergologica,
K Ikeda, and R Nagai, and T Sakamoto, and H Sano, and T Araki, and N Sakata, and H Nakayama, and M Yoshida, and S Ueda, and S Horiuchi
Immunochemical characterization of anti-acetylcholinesterase inhibitory monoclonal antibodies.
June 1993, Chemico-biological interactions,
K Ikeda, and R Nagai, and T Sakamoto, and H Sano, and T Araki, and N Sakata, and H Nakayama, and M Yoshida, and S Ueda, and S Horiuchi
Immunochemical characterization of anti-albumin antibodies in liver diseases.
February 1983, Clinical immunology and immunopathology,
K Ikeda, and R Nagai, and T Sakamoto, and H Sano, and T Araki, and N Sakata, and H Nakayama, and M Yoshida, and S Ueda, and S Horiuchi
Production and immunochemical characterization of mouse monoclonal antibodies to human Lewis blood group structures.
January 1984, Experimental and clinical immunogenetics,
K Ikeda, and R Nagai, and T Sakamoto, and H Sano, and T Araki, and N Sakata, and H Nakayama, and M Yoshida, and S Ueda, and S Horiuchi
Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody.
January 1991, International journal of clinical & laboratory research,
K Ikeda, and R Nagai, and T Sakamoto, and H Sano, and T Araki, and N Sakata, and H Nakayama, and M Yoshida, and S Ueda, and S Horiuchi
Immunochemical characterization of anti-acetylcholine receptor antibodies in primary biliary cirrhosis.
June 1988, Journal of hepatology,
K Ikeda, and R Nagai, and T Sakamoto, and H Sano, and T Araki, and N Sakata, and H Nakayama, and M Yoshida, and S Ueda, and S Horiuchi
Immunochemical characterization of human antibodies to lymphoblastoid interferon.
December 1991, Clinical and experimental immunology,
K Ikeda, and R Nagai, and T Sakamoto, and H Sano, and T Araki, and N Sakata, and H Nakayama, and M Yoshida, and S Ueda, and S Horiuchi
Monoclonal rat anti-Torpedo electroplax nicotinic acetylcholine receptor antibodies: immunochemical characterization.
November 1984, Journal of immunological methods,
K Ikeda, and R Nagai, and T Sakamoto, and H Sano, and T Araki, and N Sakata, and H Nakayama, and M Yoshida, and S Ueda, and S Horiuchi
Anti-idiotypic antisera in man. I. Production and immunochemical characterization of anti-idiotypic antisera to human antitetanus antibodies.
October 1978, Journal of immunology (Baltimore, Md. : 1950),
K Ikeda, and R Nagai, and T Sakamoto, and H Sano, and T Araki, and N Sakata, and H Nakayama, and M Yoshida, and S Ueda, and S Horiuchi
Anti-human FSH receptor monoclonal antibodies: immunochemical and immunocytochemical characterization of the receptor.
February 1996, Biochemistry,
Copied contents to your clipboard!